This Monday, May 25, the robotic surgery and reconstructive plastic surgery service was inaugurated at the Hospital Universitario de Caracas, with the participation of interim president Delcy Rodríguez.

The services are part of the “Health and Life 2026 Plan,” a public policy aimed at strengthening the public health system.”

#Galería 📸 | Presidenta (E) Delcy Rodríguez, lideró la activación de una Unidad de Robótica con Quirófano Automatizado y una nueva Unidad de Cirugía Plástica Reconstructiva para Pacientes Oncológicos Post-operados en el Instituto Autónomo Hospital Universitario de Caracas (HUC) pic.twitter.com/Q0mRavzzqg

— Ministerio de Comunicación e Información (@mippci_ven) May 25, 2026

During the inauguration, Rodríguez thanked the People’s Republic of China for its cooperation, stating that “this pilot center of the Hospital Universitario de Caracas is being equipped with Chinese technology.” He added that services will be provided in urology, gynecology, thoracic surgery, and general surgery.

For his part, the director of the University Clinical Hospital, Dr. Luis Lira, emphasized that this new “state-of-the-art multi-arm device will not only optimize the precision of complex surgical procedures, but will also have a direct impact on the teaching role of the university hospital.”

M.Pino

Source: ultimasnoticias

(Reference image source: Social Network X, @mippci_ven)

Follow our news on Google! For current, interesting, and accurate information, click here to see all the content on Bitfinance.news. You can also find us on X/Twitter and Instagram

La entrada Hospital Universitario de Caracas inaugurates robotic surgery aervice apareció primero en Bitfinance.

The Cuban drug Jusvinza is advancing to the second phase of clinical trials, demonstrating its effectiveness in relieving pain and inflammation in secondary joints in patients recovering from the chikungunya virus.

This was reported by Julio Baldomero, director of Clinical Research at the Center for Genetic Engineering and Biotechnology (CIGB).

According to the specialist, “the final data confirmed the hypothesis put forward by the researchers.” In this regard, Baldomero stated that they managed to resolve the “painful and inflammatory symptoms of the joints caused by this virus, which is transmitted by mosquitoes and has affected tropical regions of the world.”

What is Jusvinza?

The medication is essentially an innovative therapeutic product developed at the CIGB (Center for Genetic Engineering and Biotechnology). The active ingredient “is a peptide originally designed to treat rheumatoid arthritis” that was incorporated into the Cuban national protocol during the COVID-19 pandemic for use in “severely ill patients, helping to reduce mortality on the Caribbean island before the arrival of vaccines.”

Clinical trials with promising results

In early December 2025, two clinical trials began to verify the therapeutic effect and safety of Jusvinza in these types of patients.

“The first study was conducted at the Diez de Octubre Clinical Surgical Teaching Hospital in Havana and included 174 people in the post-acute stage; while the second was carried out at the Faustino Pérez Provincial Clinical Surgical Teaching Hospital in the western province of Matanzas, with 120 individuals in the chronic stage of the disease.”

The conclusions of both studies indicate that 70 % of the patients achieved the expected results. Specialists demonstrated the efficacy and safety of the product. Furthermore, it was found that “it is not only effective in relieving joint symptoms, but its effects are long-lasting, preventing patients from developing the chronic form of the disease.”

M.Pino

Source: xinhuanet

(Reference image source: Louis Reed on Unsplash)

Follow our news on Google! For current, interesting, and accurate information, click here to see all the content on Bitfinance.news. You can also find us on X/Twitter and Instagram

La entrada Cuba tests drug that relieves painful aftereffects of Chikungunya virus apareció primero en Bitfinance.

According to recent statements by the president of the Venezuelan Chamber of Pharmacies (Cavefar), Alicia Pinedo, a 100 % guarantee of medicine supply nationwide is in place.

The executive emphasized on Monday, January 5, that inventory replenishment will be carried out continuously and in all states of the country, asserting that “the pharmaceutical sector has a high level of commitment.”

Pinedo indicated that the pharmaceutical sector guarantees full supply “and a minimum of 85 %.” She also emphasized that the country is producing medicines in line with demand and that the products are being distributed.

This allowed for the complete restocking of medicine shelves during the industry’s collective vacation period between November and December, ensuring that production did not slow down, and that shortages did not occur.

In a joint effort with government sectors, the industry has a guaranteed supply of diesel fuel “so that distribution can take place, and therefore inventory replenishment will be carried out continuously and in all states of the country,” Pinedo explained in an interview with Unión Radio.

M.Pino

Source: bancaynegocios

(Reference image source: Árpád Czapp on Unsplash)        

Visit our news channel on Google News and follow us to get accurate, interesting information and stay up to date with everything. You can also see our daily content on X/Twitter and Instagram

La entrada Cavefar guarantees nationwide medicine supply apareció primero en Bitfinance.

Venezuelan Minister of Science and Technology, Gabriela Jiménez, provided details last Thursday about the work of researchers from the Venezuelan Institute of Scientific Research (IVIC) on a project to improve breast cancer treatment.

Jiménez indicated that the scientists are also focusing on ways to reduce the side effects of chemotherapy and radiotherapy on patients. The official posted on Instagram: “The objective of this project is to modify the drug used for breast cancer, such as Tamoxifen, and achieve synergy with a gadolinium atom to obtain positive therapeutic and radiotherapeutic effects.”

She emphasized that the IVIC team of scientists seeks “through a molecule, to reduce the adverse effects of chemotherapy.”

For his part, Álvaro Álvarez, PhD in Chemistry and project leader, noted that the objective of this project is also to reduce the dose and potency of radiation, which, he said, “also causes some inconveniences for patients.”

Álvarez explained in a video: “Once the rational synthesis has been completed, and the characterization tests have been performed, the idea is to test it on cell lines in vitro. Once that occurs, and if we are successful, it would then be tested in vivo on specimens.”

M.Pino

Source: elaragueno

(Reference image source: Trust “Tru” Katsande on Unsplash)

Visit our news channel on Google News and follow us to get accurate, interesting information and stay up to date with everything. You can also see our daily content on X/Twitter and Instagram

La entrada Venezuelan scientists work on a project to improve breast cancer treatment apareció primero en Bitfinance.